Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1513–1536 of 6,232 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Weekly Assessment Clear all

Conditions: Colon Cancer, Rectal Cancer
Interventions: lenalidomide, cetuximab, mutation analysis, polymerase chain reaction, polymorphism analysis; Drug · Biological · Other + 1 more
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Lymphoma
Interventions: Enhanced Usual Care, SMART3RP-Lymphoma; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 254 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Stroke
Interventions: CARE-CITE, Standard of care; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 21 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Breast Carcinoma, Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Recurrent Breast Carcinoma
Interventions: Best Practice, Medical Chart Review, Quality-of-Life Assessment, Questionnaire Administration, Supportive Care; Other · Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 287 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Major Depressive Disorder
Interventions: 250 mg DCS, 100 mg Modafinil, Placebo; Drug
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years to 65 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Stroke, Stroke, Acute, Cerebrovascular Accident, Cerebrovascular Accident, Acute
Interventions: Ekso gait training, Standard physical therapy; Device · Procedure
Lead sponsor: Sunnyview Rehabilitation Hospital; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Schenectady, New York

Conditions: Colon Cancer, Rectal Cancer
Interventions: cholecalciferol; Dietary Supplement
Lead sponsor: Legacy Health System; Other
Eligibility: 18 Years to 99 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 3
States / cities: Gresham, Oregon • Portland, Oregon • Tualatin, Oregon

Conditions: Multiple Myeloma
Interventions: Belantamab mafodotin, Lenalidomide, Dexamethasone, Bortezomib; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 12
States / cities: Birmingham, Alabama • Goodyear, Arizona • Atlanta, Georgia + 9 more

Conditions: ADHD
Interventions: Continuous Tai Chi and Mindful Movement classes; Other
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 8 Years to 15 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Autistic Disorder, Autism Spectrum Disorder, Asperger's Syndrome, Pervasive Developmental Disorder
Interventions: Cognitive Enhancement Therapy, Enriched Supportive Therapy; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 16 Years to 45 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: ADHD
Interventions: Tai Chi; Behavioral
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 8 Years to 12 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Latent Tuberculosis Infection
Interventions: Self Administered Therapy (SAT), SMS reminders, isoniazid and rifapentine; Behavioral · Drug
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years and older
Enrollment: 1,002 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 9
States / cities: San Francisco, California • Denver, Colorado • Washington D.C., District of Columbia + 5 more

Conditions: Obesity, Overweight, Overeating, Weight, Childhood Obesity
Interventions: Family Based Behavioral Treatment; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 8 Years to 12 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Oppositional Defiant Disorder, Conduct Disorder
Interventions: MFG therapy, Standard of Care; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 7 Years and older
Enrollment: 416 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Physical Activity, End Stage Kidney Disease, Hemodialysis
Interventions: Fitbit; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: San Diego, California

Conditions: PreDiabetes, Weight Loss, Lifestyle Risk Reduction
Interventions: Diabetes Prevention Program-Remote (DPP-R), Diabetes Prevention Program-Facebook (DPP-FB); Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Chronic Musculoskeletal Pain, Veterans, Music Therapy
Interventions: Stepped-care; Behavioral
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Overweight and Obesity, Pre-Diabetes, High Blood Pressure
Interventions: Educational Group Weight Loss Classes, Home Gardening Intervention; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 30 Years and older · Female only
Enrollment: 273 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Birmingham, Alabama • Jackson, Mississippi

Conditions: Polymyositis, Dermatomyositis
Interventions: KZR-616; Drug
Lead sponsor: Kezar Life Sciences, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 9
States / cities: Beverly Hills, California • Orange, California • Miami, Florida + 6 more

Conditions: Spinal and Bulbar Muscular Atrophy
Interventions: BVS857, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 3
States / cities: Orange, California • Bethesda, Maryland • Columbus, Ohio

Conditions: Group Meetings
Interventions: TIPSTART; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years to 34 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Health Behavior
Interventions: AWAKE; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 13 Years to 17 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Childhood Obesity
Interventions: Exergaming Condition; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 10 Years to 12 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Crohn's Disease
Interventions: Certolizumab Pegol (CDP870); Biological
Lead sponsor: UCB Pharma SA; Industry
Eligibility: 18 Years and older
Enrollment: 310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2012
U.S. locations: 41
States / cities: Birmingham, Alabama • Huntsville, Alabama • Little Rock, Arkansas + 37 more

Search by objective public record fields.

Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

Carepartner Collaborative Integrated Therapy in Sub-Acute Stroke

Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer

Improving Therapeutic Learning in Depression: Proof of Concept

Achieving Meaningful Clinical Benchmarks With Ekso Gait Training During Acute Stroke Inpatient Rehabilitation.

Effectiveness of High Dose Vitamin D Supplementation in Stage III Colorectal Cancer

To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Ongoing Tai Chi Training for Children With ADHD

Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder

Tai Chi Training for Children With ADHD

Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT

Family Based Treatment for Weight Loss With Breakfast Prescription

Multi-Family Group Therapy for Reducing Behavioral Difficulties in Youth

The "Step4Life" Randomized Control Trial in Hemodialysis

The National Diabetes Prevention Program in Rural Communities

Stepped-Care Intervention of Music and Imagery to Assess Relief (SCIMITAR) Trial

Stepping Into Lifestyle Changes

Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.

Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy

Feasibility of Therapy Integrating Peer-sharing, Technology, Aerobic and Resistance Training (TIPSTART)

Improving Health-Promoting Behaviors in Adolescent Cancer Survivors Using AWAKE: A Feasibility Trial

Gaming Technology to Encourage Healthy Weight and Activity in Youth

A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease